Current Drug Targets - Inflammation & Allergy

Continued as Inflammation & Allergy - Drug Targets

Personal Subscription
Volume: 1 Issue: 2, June

The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities

Volume:1   Issue: 2
Pp: 127-136
Leonard Buckbinder and Ralph P. Robinson
DOI: 10.2174/1568010023344751
Published on: 01 March, 2012

Upstream Signal Transduction of NF-κB Activation

Volume:1   Issue: 2
Pp: 137-149
Fei Chen, Laurence M. Demers and Xianglin Shi
DOI: 10.2174/1568010023344706
Published on: 01 March, 2012

Current and Future Therapeutic Strategies to Target Inflammation in Stroke

Volume:1   Issue: 2
Pp: 151-166
Wandong Zhang and Danica Stanimirovic
DOI: 10.2174/1568010023344689
Published on: 01 March, 2012

Mechanisms of Antihistamines and Mast Cell Stabilizers in Ocular Allergic Inflammation

Volume:1   Issue: 2
Pp: 167-180
E.B. Cook, J.L. Stahl and F.M. Graziano
DOI: 10.2174/1568010023344733
Published on: 01 March, 2012

Toll-Like Receptors and Inflammation in the CNS

Volume:1   Issue: 2
Pp: 181-191
Sung Joong Lee and Soojin Lee
DOI: 10.2174/1568010023344698
Published on: 01 March, 2012

Cytokines in Dementias

Volume:1   Issue: 2
Pp: 193-200
Elisabeth Tarkowski
DOI: 10.2174/1568010023344670
Published on: 01 March, 2012

Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease

Volume:1   Issue: 2
Pp: 201-214
E.M. Erin, T.J. Williams, P.J. Barnes and T.T. Hansel
DOI: 10.2174/1568010023344715
Published on: 01 March, 2012